Introduction:Basic information about CAS 2207-75-2|Potassium oxonate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Potassium oxonate |
|---|
| CAS Number | 2207-75-2 | Molecular Weight | 195.175 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C4H2KN3O4 | Melting Point | 300 °C(lit.) |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | potassium,4,6-dioxo-1H-1,3,5-triazine-2-carboxylate |
|---|
| Synonym | More Synonyms |
|---|
Potassium oxonate BiologicalActivity
| Description | Oxonic acid potassium salt is an inhibitor of uricase, oxonic inhibits the phosphorylation of 5-FU to 5-fluorouridine-5'-monophosphate catalyzed by pyrimidine phosphoribosyl-transferase in a different manner from allopurinol in cell-free extracts and intact cells in vitro.IC50 value: Target: On p.o. administration of 5-FU (2 mg/kg) and a potent inhibitor of 5-FU degradation to Yoshida sarcoma-bearing rats, oxonic acid (10 mg/kg) was found to inhibit the formation of 5-fluorouridine-5'-monophosphate from 5-FU and its subsequent incorporation into the RNA fractions of small and large intestine but not of tumor and bone marrow tissues [1]. Oxonic acid diet increased plasma uric acid by 80-90 micromol/l, while blood pressure was elevated only in hyperuricemic 5/6 nephrectomy rats (18 mmHg) [2]. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Metabolic Disease |
|---|
| References | [1]. Shirasaka T, et al. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res. 1993 Sep 1;53(17):4004-9. [2]. Eraranta A, et al. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency. J Hypertens. 2008 Aug;26(8):1661-8. |
|---|
Chemical & Physical Properties
| Melting Point | 300 °C(lit.) |
|---|
| Molecular Formula | C4H2KN3O4 |
|---|
| Molecular Weight | 195.175 |
|---|
| Exact Mass | 194.968231 |
|---|
| PSA | 118.74000 |
|---|
| InChIKey | IAPCTXZQXAVYNG-UHFFFAOYSA-M |
|---|
| SMILES | O=C([O-])c1nc(=O)[nH]c(=O)[nH]1.[K+] |
|---|
| Storage condition | Refrigerator, Under Inert Atmosphere |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- RR4580000
- CHEMICAL NAME :
- Oxonic acid, potassium salt
- CAS REGISTRY NUMBER :
- 2207-75-2
- LAST UPDATED :
- 199704
- DATA ITEMS CITED :
- 3
- MOLECULAR FORMULA :
- C4-H3-N3-O4.K
- MOLECULAR WEIGHT :
- 196.20
- WISWESSER LINE NOTATION :
- T6MVMVNJ FVO &-KA-
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 3 gm/kg
- SEX/DURATION :
- female 8-9 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Specific Developmental Abnormalities - body wall
- REFERENCE :
- TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,299,1976
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 4500 mg/kg
- SEX/DURATION :
- female 8-10 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - Central Nervous System
- REFERENCE :
- TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,299,1976
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 10800 ug/kg
- SEX/DURATION :
- female 9-11 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
- REFERENCE :
- TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,289,1976
|
Safety Information
| Hazard Codes | Xn |
|---|
| Safety Phrases | S24/25 |
|---|
| WGK Germany | 3 |
|---|
| RTECS | RR4580000 |
|---|
| HS Code | 2933699090 |
|---|
Customs
| HS Code | 2933699090 |
|---|
| Summary | 2933699090 other compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0% |
|---|
Synonyms
| 1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-, potassium salt (1:1) |
| Allantoxanic acid |
| monopotassium 1,2,3,4-tetrahydro-2,4-dioxo-1,3,5-triazine-6-carboxylate |
| Potassium Oxonate |
| Oxonic acid potassium salt |
| Oxonic acid |
| Potassium 4,6-Dihydroxy-1,3,5-triazine-2-carboxylate |
| Potassium azaorotate |
| Oxonate |
| MFCD00010565 |
| Potassium Allantoxanate |
| 5-Aza-orotsaeure K-Salz |
| potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylate |
| Potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylate |
| Allantoxanic Acid Potassium Salt |
| Oxonic acid,potassium salt |
| Oteracil potassium |
| Oxonate,potassium |
| EINECS 218-627-5 |